Duke University Medical Center, Investigational Chemotherapy Services is a clinical research site located in Durham, North Carolina, United States 27710.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
Duke University Medical Center, Investigational Chemotherapy Services has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Malignant Melanoma, Carcinoma, Non-Small-Cell Lung, Brain Neoplasms, Primary.
Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer.
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Duke University Medical Center, Investigational Chemotherapy Services has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Duke University Medical Center, Investigational Chemotherapy Services has 2 clinical trials on record, with 1 currently active. Their work covers Malignant Melanoma, Carcinoma, Non-Small-Cell Lung, Brain Neoplasms, Primary.
Duke University Medical Center, Investigational Chemotherapy Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.